ZA964247B - Method of treating chronic progressive vascular diseases - Google Patents

Method of treating chronic progressive vascular diseases

Info

Publication number
ZA964247B
ZA964247B ZA964247A ZA964247A ZA964247B ZA 964247 B ZA964247 B ZA 964247B ZA 964247 A ZA964247 A ZA 964247A ZA 964247 A ZA964247 A ZA 964247A ZA 964247 B ZA964247 B ZA 964247B
Authority
ZA
South Africa
Prior art keywords
vascular diseases
treating chronic
chronic progressive
progressive vascular
treating
Prior art date
Application number
ZA964247A
Other languages
English (en)
Inventor
Gary E Striker
Liliane J Striker
Fred P Sherman
Original Assignee
Baker Norton Pharma
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baker Norton Pharma, Us Health filed Critical Baker Norton Pharma
Publication of ZA964247B publication Critical patent/ZA964247B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
ZA964247A 1995-06-07 1996-05-27 Method of treating chronic progressive vascular diseases ZA964247B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/478,347 US5643892A (en) 1995-06-07 1995-06-07 Method of treating chronic progressive vascular diseases
BR9704114-9A BR9704114A (pt) 1995-06-07 1997-07-28 Processo de tratamento de doenças vasculares progressivas crÈnicas

Publications (1)

Publication Number Publication Date
ZA964247B true ZA964247B (en) 1996-12-04

Family

ID=25664870

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA964247A ZA964247B (en) 1995-06-07 1996-05-27 Method of treating chronic progressive vascular diseases

Country Status (14)

Country Link
US (1) US5643892A (fr)
EP (1) EP0809505B1 (fr)
AU (1) AU699012B2 (fr)
BR (1) BR9704114A (fr)
CA (1) CA2210351C (fr)
DE (1) DE809505T1 (fr)
ES (1) ES2115571T3 (fr)
HU (1) HUP9802431A3 (fr)
IL (1) IL121217A (fr)
NO (1) NO313686B1 (fr)
NZ (1) NZ309991A (fr)
TW (1) TW434018B (fr)
WO (1) WO1996040158A1 (fr)
ZA (1) ZA964247B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010005720A1 (en) * 1995-06-07 2001-06-28 U.S.A. As Represented By The Secretary Department Of Health And Human Services Method of treating chronic progressive vascular scarring diseases
US6255295B1 (en) 1996-12-23 2001-07-03 Nutramax Laboratories, Inc. Aminosugar, glycosaminoglycan or glycosaminoglycan-like compounds, and s-adenosylmethionine composition for the protection, treatment, repair, and reduction of inflammation of connective tissue
UA65587C2 (en) * 1997-10-09 2004-04-15 Baker Norton Pharma Method for preventing nephrotoxicity induced by cyclosporins or tacrolimus
DE19747195A1 (de) * 1997-10-24 1999-04-29 Knoll Ag Verwendung von Glykosaminoglykanen zur Herstellung von pharmazeutischen Zubereitungen zur Behandlung von mit Diabetes assoziierten Augenkrankheiten
WO2001052867A1 (fr) 2000-01-19 2001-07-26 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Utilisation de polysulfate de pentosan pour le traitement de certains troubles de la prostate
US20080214480A1 (en) * 2005-07-22 2008-09-04 Trf Pharma, Inc. Method for Treating Sickle Cell Disease and Sickle Cell Disease Sequalae
WO2007123800A2 (fr) * 2006-04-03 2007-11-01 Nutramax Laboratories, Inc. Formulations de polysulfate de pentosane stabilisé (pps) et procédés d'analyse de ces dernières
WO2010103837A1 (fr) 2009-03-11 2010-09-16 ゼライス株式会社 Inhibiteur de progression ou agent prophylactique pour l'athérosclérose, agent d'abaissement du niveau sanguin de cholestérol et produit alimentaire fonctionnel ou produit alimentaire pour des utilisations spécifiques pour la santé
US8871741B2 (en) * 2010-01-15 2014-10-28 Icahn School Of Medicine At Mount Sinai Inhibition of TNF-α induced activation of NFKB by pentosan polysulfate
US9155784B2 (en) 2011-06-20 2015-10-13 Icahn School Of Medicine At Mount Sinai Anti-TNF-α therapy for the mucopolysaccharidoses and other lysosomal disorders
US20130273096A1 (en) * 2011-10-05 2013-10-17 Bruce A. Daniels Therapeutic Sulfated Polysaccharides, Compositions Thereof, and Methods for Treating Patients
WO2020039480A1 (fr) 2018-08-20 2020-02-27 株式会社レクメド Nouvelle préparation de pentosane polysulfate sodique

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4966890A (en) * 1986-04-04 1990-10-30 Angiogenics, Ltd. Method and composition for arresting angiogenesis and capillary, cell or membrane leakage
US4820693A (en) * 1986-05-22 1989-04-11 Angiogenics, Ltd. Method and composition for arresting angiogenesis and capillary, cell or membrane leakage
DE3725554A1 (de) * 1987-08-01 1989-02-09 Hoechst Ag Pharmazeutisches kombinationspraeparat sowie dessen herstellung und verwendung
US5032679A (en) * 1988-12-15 1991-07-16 Glycomed, Inc. Heparin fragments as inhibitors of smooth muscle cell proliferation
EP0466315A3 (en) * 1990-05-30 1992-07-01 Larrian Gillespie Compositions containing xylan sulphates for affecting growth factor function and for inhibiting fibroblast proliferation
US5605938A (en) * 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate

Also Published As

Publication number Publication date
EP0809505A4 (fr) 1998-07-01
WO1996040158A1 (fr) 1996-12-19
US5643892A (en) 1997-07-01
ES2115571T3 (es) 2003-09-01
IL121217A0 (en) 1999-10-28
NO313686B1 (no) 2002-11-18
DE809505T1 (de) 1998-05-28
CA2210351A1 (fr) 1996-12-19
CA2210351C (fr) 2003-09-23
IL121217A (en) 2000-09-28
NO973081D0 (no) 1997-07-02
BR9704114A (pt) 2000-06-06
EP0809505B1 (fr) 2003-04-02
HUP9802431A2 (hu) 1999-02-01
NO973081L (no) 1997-08-27
AU6030096A (en) 1996-12-30
TW434018B (en) 2001-05-16
AU699012B2 (en) 1998-11-19
EP0809505A1 (fr) 1997-12-03
HUP9802431A3 (en) 2001-06-28
ES2115571T1 (es) 1998-07-01
NZ309991A (en) 2001-03-30

Similar Documents

Publication Publication Date Title
IL117417A0 (en) Method of treating cardiac inflammatory disease
PL324284A1 (en) Methods of treating diabetes
ZA965088B (en) Methods of preventing or treating allergles
GB9620892D0 (en) Methods of treating RAF mediated diseases
AUPN271295A0 (en) Method of treatment
IL112590A0 (en) Novel method for treatment of renal diseases
EP0729361A4 (fr) Procede de traitement de troubles neurologiques
ZA964247B (en) Method of treating chronic progressive vascular diseases
PL327600A1 (en) Method of treating depressions
ZA982246B (en) Method of treating chronic progressive vascular scarring diseases
GB9515868D0 (en) Therapeutic method
HUP9900138A3 (en) Method for treatment of wood element
EP0828507A4 (fr) Technique de traitement de la douleur
GB9507825D0 (en) Method of treatment
GB9415902D0 (en) Method of treatment
HK1025044A (en) Method of treating chronic progressive vascular scarring diseases
ZA968097B (en) Treatment of chronic progressive renal fallure
GB9407335D0 (en) Method of treatment
PL313573A1 (en) Method of enhancing a healing process of some chronic diseases
GB9516795D0 (en) Method of treatment
GB9523655D0 (en) Method of treatment
GB9500723D0 (en) Method of treatment
GB9500396D0 (en) Method of treatment
GB9502514D0 (en) Method of treatment
GB9508963D0 (en) Method of treatment